QQQ   292.38 (+0.73%)
AAPL   142.94 (-0.04%)
MSFT   245.01 (+0.95%)
META   148.06 (+0.68%)
GOOGL   97.64 (+0.72%)
AMZN   102.97 (+2.41%)
TSLA   171.96 (+3.18%)
NVDA   194.52 (+1.51%)
NIO   12.31 (+2.41%)
BABA   111.77 (+0.51%)
AMD   74.00 (+2.14%)
T   20.30 (+0.69%)
MU   59.87 (-2.98%)
F   13.39 (+3.88%)
CGC   2.92 (+2.82%)
GE   80.60 (-0.28%)
DIS   108.07 (+0.45%)
AMC   5.14 (+2.59%)
PFE   43.56 (+0.02%)
PYPL   80.23 (+0.74%)
NFLX   352.37 (-0.21%)
QQQ   292.38 (+0.73%)
AAPL   142.94 (-0.04%)
MSFT   245.01 (+0.95%)
META   148.06 (+0.68%)
GOOGL   97.64 (+0.72%)
AMZN   102.97 (+2.41%)
TSLA   171.96 (+3.18%)
NVDA   194.52 (+1.51%)
NIO   12.31 (+2.41%)
BABA   111.77 (+0.51%)
AMD   74.00 (+2.14%)
T   20.30 (+0.69%)
MU   59.87 (-2.98%)
F   13.39 (+3.88%)
CGC   2.92 (+2.82%)
GE   80.60 (-0.28%)
DIS   108.07 (+0.45%)
AMC   5.14 (+2.59%)
PFE   43.56 (+0.02%)
PYPL   80.23 (+0.74%)
NFLX   352.37 (-0.21%)
QQQ   292.38 (+0.73%)
AAPL   142.94 (-0.04%)
MSFT   245.01 (+0.95%)
META   148.06 (+0.68%)
GOOGL   97.64 (+0.72%)
AMZN   102.97 (+2.41%)
TSLA   171.96 (+3.18%)
NVDA   194.52 (+1.51%)
NIO   12.31 (+2.41%)
BABA   111.77 (+0.51%)
AMD   74.00 (+2.14%)
T   20.30 (+0.69%)
MU   59.87 (-2.98%)
F   13.39 (+3.88%)
CGC   2.92 (+2.82%)
GE   80.60 (-0.28%)
DIS   108.07 (+0.45%)
AMC   5.14 (+2.59%)
PFE   43.56 (+0.02%)
PYPL   80.23 (+0.74%)
NFLX   352.37 (-0.21%)
QQQ   292.38 (+0.73%)
AAPL   142.94 (-0.04%)
MSFT   245.01 (+0.95%)
META   148.06 (+0.68%)
GOOGL   97.64 (+0.72%)
AMZN   102.97 (+2.41%)
TSLA   171.96 (+3.18%)
NVDA   194.52 (+1.51%)
NIO   12.31 (+2.41%)
BABA   111.77 (+0.51%)
AMD   74.00 (+2.14%)
T   20.30 (+0.69%)
MU   59.87 (-2.98%)
F   13.39 (+3.88%)
CGC   2.92 (+2.82%)
GE   80.60 (-0.28%)
DIS   108.07 (+0.45%)
AMC   5.14 (+2.59%)
PFE   43.56 (+0.02%)
PYPL   80.23 (+0.74%)
NFLX   352.37 (-0.21%)
NASDAQ:DARE

Daré Bioscience - DARE Stock Forecast, Price & News

$1.27
+0.03 (+2.41%)
(As of 01/31/2023 10:57 AM ET)
Add
Compare
Today's Range
$1.26
$1.28
50-Day Range
$0.82
$1.36
52-Week Range
$0.82
$1.88
Volume
87,351 shs
Average Volume
485,148 shs
Market Capitalization
$108.15 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50

Daré Bioscience MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
629.2% Upside
$9.33 Price Target
Short Interest
Healthy
1.39% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.13mentions of Daré Bioscience in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From ($0.32) to ($0.35) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.05 out of 5 stars

Medical Sector

618th out of 1,055 stocks

Pharmaceutical Preparations Industry

311th out of 518 stocks


DARE stock logo

About Daré Bioscience (NASDAQ:DARE) Stock

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Receive DARE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter.

DARE Stock News Headlines

The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Maxim Group Keeps Their Buy Rating on Daré Bioscience (DARE)
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Dare Bioscience
H.C. Wainwright Reaffirms Their Buy Rating on Daré Bioscience (DARE)
See More Headlines
Receive DARE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Daré Bioscience and its competitors with MarketBeat's FREE daily newsletter.

DARE Company Calendar

Last Earnings
11/10/2022
Today
1/31/2023
Next Earnings (Estimated)
3/30/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:DARE
Employees
16
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$9.33
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+331.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-38,700,000.00
Pretax Margin
-245.47%

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.51 per share

Miscellaneous

Free Float
81,432,000
Market Cap
$108.15 million
Optionable
Not Optionable
Beta
1.17

Key Executives

  • Sabrina Martucci Johnson
    President, CEO, Secretary & Director
  • Mark Walters
    Vice President-Operations
  • Lisa Walters-Hoffert
    Chief Financial Officer
  • Christine Mauck
    Medical Director
  • David Friend
    Chief Scientific Officer













DARE Stock - Frequently Asked Questions

Should I buy or sell Daré Bioscience stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Daré Bioscience in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DARE shares.
View DARE analyst ratings
or view top-rated stocks.

What is Daré Bioscience's stock price forecast for 2023?

4 analysts have issued 12 month price objectives for Daré Bioscience's stock. Their DARE share price forecasts range from $4.00 to $17.00. On average, they anticipate the company's share price to reach $9.33 in the next year. This suggests a possible upside of 649.7% from the stock's current price.
View analysts price targets for DARE
or view top-rated stocks among Wall Street analysts.

How have DARE shares performed in 2023?

Daré Bioscience's stock was trading at $0.83 at the beginning of 2023. Since then, DARE shares have increased by 50.0% and is now trading at $1.2450.
View the best growth stocks for 2023 here
.

Are investors shorting Daré Bioscience?

Daré Bioscience saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,180,000 shares, a decline of 13.2% from the December 31st total of 1,360,000 shares. Based on an average trading volume of 229,500 shares, the days-to-cover ratio is currently 5.1 days.
View Daré Bioscience's Short Interest
.

When is Daré Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 30th 2023.
View our DARE earnings forecast
.

How were Daré Bioscience's earnings last quarter?

Daré Bioscience, Inc. (NASDAQ:DARE) posted its earnings results on Thursday, November, 10th. The biotechnology company reported ($0.08) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.03.

What other stocks do shareholders of Daré Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Daré Bioscience investors own include FuelCell Energy (FCEL), Inovio Pharmaceuticals (INO), VBI Vaccines (VBIV), Vaxart (VXRT), Tonix Pharmaceuticals (TNXP), Matinas BioPharma (MTNB), Novavax (NVAX), Gilead Sciences (GILD), SCYNEXIS (SCYX) and Sorrento Therapeutics (SRNE).

What is Daré Bioscience's stock symbol?

Daré Bioscience trades on the NASDAQ under the ticker symbol "DARE."

Who are Daré Bioscience's major shareholders?

Daré Bioscience's stock is owned by a number of institutional and retail investors. Top institutional investors include Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Daré Bioscience?

Shares of DARE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Daré Bioscience's stock price today?

One share of DARE stock can currently be purchased for approximately $1.25.

How much money does Daré Bioscience make?

Daré Bioscience (NASDAQ:DARE) has a market capitalization of $105.61 million and generates $10 million in revenue each year. The biotechnology company earns $-38,700,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis.

How can I contact Daré Bioscience?

Daré Bioscience's mailing address is 3655 NOBEL DRIVE SUITE 260, SAN DIEGO CA, 92122. The official website for the company is www.darebioscience.com. The biotechnology company can be reached via phone at (858) 926-7655, via email at innovations@darebioscience.com, or via fax at 617-494-1544.

This page (NASDAQ:DARE) was last updated on 1/31/2023 by MarketBeat.com Staff